BEGIN:VCALENDAR VERSION:2.0 PRODID:-//BioCT - ECPv6.3.3.1//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:BioCT X-ORIGINAL-URL:https://bioct.org X-WR-CALDESC:Events for BioCT REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20210314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20211107T060000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/New_York:20210622T110000 DTEND;TZID=America/New_York:20210622T123000 DTSTAMP:20240328T131746 CREATED:20210601T174538Z LAST-MODIFIED:20210601T174551Z UID:4767-1624359600-1624365000@bioct.org SUMMARY:Digital Therapeutics and the Future of Medicine - Hosted by JLabs DESCRIPTION:With healthcare becoming more digital\, especially over the past year\, innovators are continuing to demonstrate the power of these potential solutions. Digital Therapeutics refers to the application of evidence-based software-driven therapeutic interventions for the prevention and management of a medical disorder or disease. \nEven though the field is very young\, treatments are starting to go down the path to patients\, reshaping our understanding and management of disease. Do these innovations provide real therapeutic benefit? How have innovators progressed down innovation\, regulatory and commercial challenges? \n11:00 AM Opening Remarks\nStephen Pitt | Regional Head\, JLABS US North East\, Johnson & Johnson Innovation \n11:10 AM Presentation \n11:20 AM Panel Discussion \n12:10 PM Audience Q&A \n12:30 PM End of Broadcast URL:https://bioct.org/event/digital-therapeutics-and-the-future-of-medicine-hosted-by-jlabs/ END:VEVENT END:VCALENDAR